Skip to main content

Toxicology of Dioxins and Related Chemicals

  • Chapter
Dioxins and Health

Abstract

Chlorinated dibenzo-p-dioxins are environmental contaminants present in a variety of environmental media. This class of compounds has caused great concern in the general public as well as generated intense interest in the scientific community. The public concerns stem from the characterization of dioxin as one of the most potent “man-made” toxicants ever studied. Indeed, these compounds are extremely potent at producing a variety of toxic effects in experimental animals. The most potent of these chemicals is 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD). 2,3,7,8-TCDD and its congeners produce a wide spectrum of toxic effects including immunotoxicity, teratogenicity, carcinogenicity, and lethality. The interest in dioxins and its congeners in the scientific community arises because many of their toxic effects are associated with alterations in growth and development of a variety of different cell types present in different organs. Thus, dioxins can be used as tools to study mechanisms of growth and development. Recent laboratory studies have provided new insights into the mechanisms involved in the toxicity of dioxins. These findings, in conjunction with epidemiology studies, indicate that at least some portions of the population are exposed to concentrations of dioxins and related compounds which may be causing subtle effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. L. Birnbaum, Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus, Drug Metab. Dispos. 14, 34–40 (1986).

    PubMed  CAS  Google Scholar 

  2. T. A. Gasiewicz and G. Rucci, Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for a homologous nature among mammalian species, Mol. Pharmacol. 26, 90–98 (1984).

    PubMed  CAS  Google Scholar 

  3. R. Pohjanvirta, T. Vartiainen, A. Uusirauva, J. Monkkonen, and J. Tuomisto, Tissue distribution, metabolism, and excretion of [14C]-TCDD in a TCDD-susceptible and a TCDD-resistant rat strain, Pharmacol. Toxicol. 66, 93–100 (1990).

    Article  PubMed  CAS  Google Scholar 

  4. J. Q. Rose, J. C. Ramsey, T. H. Wentzler, R. A. Hummel, and P. J. Gehring, The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat, Toxicol. Appl. Pharmacol. 36, 209–226 (1976).

    Article  PubMed  CAS  Google Scholar 

  5. H. Poiger and C. Schlatter, Pharmacokinetics of 2,3,7,8-TCDD in man, Chemosphere 15, 1489–1494 (1986).

    Article  CAS  Google Scholar 

  6. J. L. Pirkle, W. F. Wolfe, and D. G. Patterson, Estimate of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam veterans of Operation Ranch Hand, J. Toxicol. Environ. Health 27, 165–171 (1989).

    Article  PubMed  CAS  Google Scholar 

  7. M. Van den Berg and H. Poiger, Selective retention of PCDDs and PCDFs in mammals: A multiple cause problem, Chemosphere 18, 677–680 (1989).

    Article  Google Scholar 

  8. S. R. Max and E. K. Silbergeld, Skeletal muscle glucocorticoid receptor and glutamine synthetase activity in the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicol. Appl. Pharmacol. 87, 523–527 (1987).

    Article  PubMed  CAS  Google Scholar 

  9. R. E. Peterson, M. D. Seefeld, B. J. Christian, C. L. Potter, C. K. Kellin, and R. E. Keesey, The wasting syndrome in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: Basic features and their interpretation, Banbury Report 18, 291–308 (1984).

    CAS  Google Scholar 

  10. H. Urabe, H. Koda, and M. Asahi, Present state of Yusho patients, Ann. N.Y. Acad. Sci. 320, 273–275 (1979).

    PubMed  CAS  Google Scholar 

  11. J. G. Vos, H. Van Loveren, and H.-J. Schuurman, Immunotoxicity of dioxin: Immune function and host resistance in laboratory animals and humans, Banbury Report 35, 79–93 (1991).

    CAS  Google Scholar 

  12. A. N. Tucker, S. J. Vore, and M. I. Luster, Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Mol. Pharmacol. 29, 372–377 (1986).

    PubMed  CAS  Google Scholar 

  13. J. G. Vos, J. G. Kreftenberg, H. W. B. Engel, A. Minderhoud, and L. M. van Noorle Jansen, Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced immune suppression and decreased resistance to infection: Endotoxin hypersensitivity, serum zinc concentration and effect of thymosin treatment, Toxicology 9, 75–84 (1978).

    Article  PubMed  CAS  Google Scholar 

  14. E. Benjamini and S. Leskowitz, Immunology: A Short Course, 2nd ed., p. 26, Wiley-Liss, New York (1991).

    Google Scholar 

  15. J. G. Vos and J. A. Moore, Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxins, Int. Arch. Allergy Appl. Immunol. 47, 777–791 (1974).

    Article  PubMed  CAS  Google Scholar 

  16. M. I. Luster, D. R. Boorman, J. H. Dean, M. H. Harris, R. W. Luebke, M. L. Padarathigh, and J. A. Moore, Examination of bone marrow, immunologic parameters and host susceptibility following pre-and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), Int. J. Immunopharmacol. 2, 310–320 (1980).

    Google Scholar 

  17. R. Kimbrough, Skin lesions in animals and humans: A brief overview, Banbury Report 18, 357–364(1984).

    Google Scholar 

  18. E. E. McConnell and J. A. Moore, Toxicopathology characteristics of the halogenated aromatics, Ann. N.Y. Acad. Sci. 320, 138–150 (1979).

    PubMed  CAS  Google Scholar 

  19. J. G. Zinkl, J. G. Vos, J. A. Moore, and B. N. Gupta, Hematologic and clinical chemistry effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals, Environ. Health Per-spect. 5, 111–118(1973).

    Article  CAS  Google Scholar 

  20. J. R. Allen, L. A. Carstens, and D. A. Barsotti, Residual effects of short-term low-level exposure of nonhuman primates to polychlorinated biphenyls, Toxicol. Appl. Pharmacol. 30, 440–451 (1974).

    Article  PubMed  CAS  Google Scholar 

  21. E. E. McConnell, J. A. Moore, and D. W. Dalgard, Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rhesus monkeys (Macaca mulatta) following a single oral dose, Toxicol. Appl. Pharmacol. 43, 175–187 (1978).

    Article  PubMed  CAS  Google Scholar 

  22. P. Mocarelli, A. Marocchi, P. Brambilla, P. M. Gerthoux, L. Colombo, A. Mondonico, and L. Meazza, Effects of dioxin exposure in humans at Seveso, Italy, Banbury Report 35, 95–100 (1991).

    CAS  Google Scholar 

  23. R. D. Hinsdill, D. L. Couch, and R. S. Speirs, Immunosuppression in mice induced by dioxin (TCDD) in feed, J. Environ. Pathol. Toxicol. 4, 401–412 (1980).

    PubMed  CAS  Google Scholar 

  24. K. L. White, H. H. Lysy, J. A. McCay, and A. C. Anderson, Modulation of serum complement levels following exposure to polychlorinated dibenzo-p-dioxins, Toxicol. Appl. Pharmacol. 84, 209–221 (1986).

    Article  PubMed  CAS  Google Scholar 

  25. R. W. Luebke, C. Copeland, D. L. Andrews, J. J. Diliberto, P. I. Acubue, and L. S. Birnbaum, Effects of TCDD on resistance to T. spiralis infection in mice, Toxicologist 13, 306 (1993).

    Google Scholar 

  26. G. R. Burelson, H. Lebrec, Y. G. Yang, J. D. Ibanes, and K. N. Pennington, Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice, submitted for publication (1993).

    Google Scholar 

  27. M.I. Luster, J. H. Dean, and J. A. Moore, Evaluation of immune functions in toxicology, in: Principles and Methods of Toxicology (A. Wallace Hayes, ed.), pp. 561–586, Raven Press, New York (1984).

    Google Scholar 

  28. R. A. Smialowicz, M. Riddle, W. Williams, J. Diliberto, D. Andrews, C. Copeland, and D. Ross, Comparison of the immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice and rats, Toxicologist 13, 1352 (1993).

    Google Scholar 

  29. C. Copeland, R. W. Luebke, and D. L. Andrews, Resistance to T. spiralis infection in rats exposed to TCDD, Toxicologist 13, 307 (1993).

    Google Scholar 

  30. Y. G. Yang and G. R. Burleson, Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the influenza virus augmented pulmonary natural killer activity of Fisher 344 rats, Toxicologist 13, 308 (1993).

    Google Scholar 

  31. A. Vecchi, A. Mantovani, M. Sironi, M. Luini, W. Cairo, and S. Garattini, Effect of acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral antibody production in mice, Chem. Biol. Interact. 30, 337–341 (1980).

    Article  PubMed  CAS  Google Scholar 

  32. R. J. Kociba, P. A. Keller, C. N. Park, and P. J. Gehring, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD): Results of a 13-week oral toxicity study in rats, Toxicol. Appl. Pharmacol. 35, 553–574 (1976).

    Article  PubMed  CAS  Google Scholar 

  33. D. A. Barsotti, L. J. Abrahamson, and J. R. Allen, Hormonal alterations in female rhesus monkeys fed a diet containing 2,3,7,8-tetrachlorodibenzo-p-dioxin, Bull Environ. Contarn. Toxicol. 211, 463–469 (1979).

    Article  Google Scholar 

  34. T. H. Umbreit, E. J. Hesse, G. J. Macdonald, and M. A. Gallo, Effects of TCDD-estradiol interactions in three strains of mice, Toxicol. Lett. 40, 1–9 (1987).

    Article  Google Scholar 

  35. D. C. Spink, D. W. Lincoln, II, H. W. Dickerman, and G. F. Gierthy, 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17-beta-estradiol metabolism in MCF-7 breast tumor cells, Proc. Natl. Acad. Sci. USA 87, 6917–6921 (1990).

    Article  PubMed  CAS  Google Scholar 

  36. M. Romkes and S. Safe, Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone as antiestrogens in female rat uterus, Toxicol. Appl. Pharmacol. 92, 368–380 (1988).

    Article  PubMed  CAS  Google Scholar 

  37. M. J. DeVito, T. Thomas, E. Martin, T. H. Umbreit, and M. A. Gallo, Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Tissue-specific regulation of estrogen receptor in CD1 mice, Toxicol. Appl. Pharmacol. 113, 284–292 (1992).

    Article  PubMed  CAS  Google Scholar 

  38. K. T. Shiverick and T. F. Muther, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) effects on hepatic microsomal steroid metabolism and serum estradiol of pregnant rats, Biochem. Pharmacol. 32, 991–995 (1983).

    Article  PubMed  CAS  Google Scholar 

  39. L. E. Gray, J. S. Ostby, W. Kelce, R. Marshall, J. J. Diliberto, and L. S. Birnbaum, Perinatal TCDD exposure alters sex differentiation in both female and male LE hooded rats, Paper presented at Dioxin ′93, Vienna, September 20–24 (1993).

    Google Scholar 

  40. J. R. Allen and J. J. Lalich, Response of chickens to prolonged feeding of crude “toxic fat,” Proc. Soc. Exp. Biol. Med. 109, 48–51 (1962).

    Article  PubMed  CAS  Google Scholar 

  41. J. R. Allen and L. A. Carstens, Light and electron microscopic observations in Macaca mulatta monkeys fed toxic fat, Am. J. Vet. Res. 28, 1513–1526 (1967).

    PubMed  CAS  Google Scholar 

  42. I. Chahoud, R. Krowke, A. Schimmel, H. Merker, and D. Neubert, Reproductive toxicity and pharmacokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin. I. Effects of high doses on the fertility of male rats, Arch. Toxicol. 63, 432–439 (1989).

    Article  PubMed  CAS  Google Scholar 

  43. R. W. Moore, J. A. Parsons, R. C. Bookstaff, and R. E. Peterson, Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicol. Appl. Pharmacol. 79, 99–111(1985).

    Article  PubMed  CAS  Google Scholar 

  44. R. W. Moore, C. R. Jefcoate, and R. E. Peterson, 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits steroidogenesis in the rat testis by inhibiting the mobilization of cholesterol to cytochrome P450ssc, Toxicol. Appl. Pharmacol. 109, 85–97 (1991).

    Article  PubMed  CAS  Google Scholar 

  45. G. M. Egeland, M. H. Sweeney, M. A. Fingerhut, W. E. Halperin, K. K. Wille, and T. M. Schnorr, Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin’s (TCDD) effect on total serum testosterone and gonadotropins in occupationally exposed men, Society of Epidemiological Research, Minneapolis (1992).

    Google Scholar 

  46. L. Birnbaum, Developmental toxicity of TCDD and related compounds: Species sensitivities and differences, Banbury Report 35, 51–68 (1991).

    CAS  Google Scholar 

  47. L. A. Couture, B. D. Abbott, and L. S. Birnbaum, A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Recent advances toward understanding the mechanism, Teratology 42, 619–632 (1990).

    Article  PubMed  CAS  Google Scholar 

  48. R. J. Stillman, In utero exposure to diethylstilbestrol: Adverse effects on the reproductive tract and reproductive performance in male and female offspring, Am. J. Ostet. Gynecol. 142, 905–921 (1982).

    CAS  Google Scholar 

  49. T. A. Mably, D. L. Bjerke, R. W. Moore, A. Gendron-Fitzpatrick, and R. E. Peterson, In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin: 3. Effects on spermatogenesis and reproductive capability, Toxicol. Appl. Pharmacol. 114, 118–126(1992).

    Article  PubMed  CAS  Google Scholar 

  50. R. M. Sharpe and N. E. Skakkebaek, Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341, 1392–1395 (1993).

    Article  PubMed  CAS  Google Scholar 

  51. F. Yamashita and M. Hayashi, Fetal PCB syndrome: Clinical features, intrauterine growth retardation and possible alterations in calcium metabolism, Environ. Health Perspect. 59, 41–45 (1985).

    Article  PubMed  CAS  Google Scholar 

  52. W. J. Rogan, B. C. Gladen, and K.-L. Hung, Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan, Science 241, 334–338 (1988).

    Article  PubMed  CAS  Google Scholar 

  53. J. A. Moore, E. E. McConnell, D. W. Dalgard, and M. W. Harris, Comparative toxicity of three halogenated dibenzofurans in guinea pigs, mice and rhesus monkeys, Ann. N.Y. Acad. Sci. 320, 151–163 (1979).

    PubMed  CAS  Google Scholar 

  54. J. Huff, 2,3,7,8-TCDD: A potent and complete carcinogen in experimental animals, Chemosphere 25, 173–176 (1992).

    Article  CAS  Google Scholar 

  55. R. Johnson, J. Tietge, and S. Botts, Carcinogenicity of 2,3,7,8-TCDD to medaka, Toxicologist 12(1), 476 (1922).

    Google Scholar 

  56. R. J. Kociba, D. G. Keyes, J. E. Beyer, R. M. Carreaon, E. E. Wade, D. A. Dittenber, R. P. Kalnins, L. E. Fauson, C. N. Parks, S. D. Barnard, R. A. Hummel, and C. G. Humitson, Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats, Toxicol. Appl. Pharmacol. 46, 279–290 (1978).

    Article  PubMed  CAS  Google Scholar 

  57. National Toxicology Program (NTP), Bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin for possible carcinogenicity (gavage study), Technical Report Series No. 102, National Toxicology Program, Research Triangle Park, NC (1982).

    Google Scholar 

  58. M. S. Rao, V. Subbarao, J. D. Prasad, and D. G. Scarpelli, Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Syrian golden hamster, Carcinogenesis 9, 1677–1679 (1988).

    Article  PubMed  CAS  Google Scholar 

  59. M. A. Fingerhut, W. E. Halperin, D. A. Mariow, L. A. Piacitelli, P. A. Honchar, M. H. Sweeney, A. L. Griefe, P. A. Dill, K. Steenland, and A. H. Suruda, Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin, N. Engl. J. Med. 324, 212–218 (1991).

    Article  PubMed  CAS  Google Scholar 

  60. A. Manz, J. Barger, and J. H. Dwyer, Cancer mortality among workers in chemical plant contaminated with dioxin, Lancet 338, 959–964 (1991).

    Article  PubMed  CAS  Google Scholar 

  61. A. Zober, P. Messerer, and P. Huber, Thirty-four year mortality follow up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident, Int. Arch. Occup. Environ. Health 62, 139–157 (1990).

    Article  PubMed  CAS  Google Scholar 

  62. J. S. Wassom, J. E. Huff, and N. A. Lotriano, A review of the genetic toxicology of chlorinated dibenzo-p-dioxins, Mutat. Res. 47, 141–160 (1977).

    Article  PubMed  Google Scholar 

  63. K. W. Turteltaub, J. S. Felton, B. L. Gledhill, J. S. Vogel, J. R. Southon, M. W. Caffee, R. C. Finkel, D. E. Nelson, I. D. Procter, and J. C. David, Accelerator mass spectrometry in biomedical dosimetry: Relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA, Proc. Natl. Acad. Sci. USA 87, 5288–5292 (1990).

    Article  PubMed  CAS  Google Scholar 

  64. H. C. Pitot, T. Goldsworthy, H. A. Campbell, and A. Poland, Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from die-thylnitrosamine, Cancer Res. 40, 3616–3620 (1980).

    PubMed  CAS  Google Scholar 

  65. M. E. Andersen, J. J. Mills, M. L. Gargas, L. Kedderis, L. S. Birnbaum, D. Neubert, and W. F. Greenlee, Modeling receptor-mediated processes with dioxins: Implications for pharmacokinetics and risk assessment, Risk Anal. 13, 25–36 (1993).

    Article  PubMed  CAS  Google Scholar 

  66. C. Portier, A. Tritscher, M. Kohn, C. Sewall, G. Clark, L. Edler, D. Hoel, and G. Lucier, Ligand/receptor binding for 2,3,7,8-TCDD: Implications for risk assessment, Fundam. Appl. Toxicol. 20, 48–56 (1993).

    Article  PubMed  CAS  Google Scholar 

  67. L. Birnbaum, The mechanism of dioxin toxicity: Relationship to risk assessment, Environ. Health Perspect. in press.

    Google Scholar 

  68. R. J. Scheuplein, M. A. Gallo, and D. A. van der Heijden, Epilogue, Banbury Report 35, 489–490 (1991).

    Google Scholar 

  69. R. Evans, The steroid and thyroid hormone superfamily, Science 240, 889–892 (1988).

    Article  PubMed  CAS  Google Scholar 

  70. K. M. Burbach, A. Poland, and C. A. Bradfield, Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor, Proc. Natl. Acad. Sci. USA 89, 8185–8189 (1992).

    Article  PubMed  CAS  Google Scholar 

  71. J. P. Whitlock, Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action, Annu. Rev. Pharmacol. Toxicol. 30, 251–277 (1990).

    Article  PubMed  CAS  Google Scholar 

  72. G. Perdew, Chemical cross-linking of the cytosolic and nuclear forms of the Ah receptor in hepatoma cell line 1c1c7, Biochem. Biophys. Res. Commun. 182, 55–62 (1992).

    Article  PubMed  CAS  Google Scholar 

  73. E. C. Hoffman, H. Reues, F. F. Chu, F. Sander, L. H. Conley, B. A. Brooks, and O. Hankinson, Cloning of a factor required for activity of the Ah (dioxin) receptor, Science 252, 954–958 (1991).

    Article  PubMed  CAS  Google Scholar 

  74. H. Reyes, S. Reisz-Porszasz, and O. Hankinson, Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor, Science 256, 1193–1195 (1992).

    Article  PubMed  CAS  Google Scholar 

  75. M. S. Denison, J. M. Fisher, and J. P. Whitlock, Jr., The recognition site for the dioxin-Ah receptor complex: Nucleotide sequence and functional analysis, J. Biol. Chem. 263, 17221–17224 (1988).

    PubMed  CAS  Google Scholar 

  76. A. Fujisawa-Sehara, K. Sogawa, M. Uamane, and Y. Fujii-Kuriyama, A DNA-binding factor specific for xenobiotic responsive elements of P-450c gene exists as a cryptic form in cytoplasm: Its possible translocation to nucleus, Proc. Natl. Acad. Sci. USA 85, 5859–5863 (1988).

    Article  PubMed  CAS  Google Scholar 

  77. A. Poland, E. Glover, and A. S. Kende, Stereospecific high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol, J. Biol. Chem. 251, 4936–4942 (1975).

    Google Scholar 

  78. B. D. Abbott, J. J. Diliberto, and L. S. Birnbaum, TCDD alters expression of glucocorticoid receptor in embryonic mouse palate, Toxicologist 13, 316 (1993).

    Google Scholar 

  79. J. A. Goldstein and P. Linko, Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin inducible forms of cytochrome P-450 in extrahepatic vs. hepatic tissues, Mol. Pharmacol 25, 185–191 (1983).

    Google Scholar 

  80. L. C. Quattrochi and R. H. Tukey, The human cytochrome cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene, Mol. Pharmacol. 36, 66–71 (1989).

    PubMed  CAS  Google Scholar 

  81. K. W. Gaido, S. C. Maness, L. S. Leonard, and W. F. Greenlee, 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and beta2 expression in a human keratinocyte cell line involves both transcriptional and post transcriptional control, J. Biol. Chem. 267, 24591–24595 (1992).

    PubMed  CAS  Google Scholar 

  82. T. M. Sutter and W. F. Greenlee, Classification of members of the Ah gene battery, Chemosphere 25, 223–225 (1992).

    Article  CAS  Google Scholar 

  83. S. Safe, Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs), Crit. Rev. Toxicol. 21, 219–238 (1990).

    Article  Google Scholar 

  84. A. Poland and E. Glover, Characterization and strain distribution pattern of the murine Ah receptor specified by the Ahd and Ahb− 3 alleles, Mol. Pharmacol. 38, 306–312 (1990).

    PubMed  CAS  Google Scholar 

  85. A. Poland and E. Glover, 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Segregation of toxicity with the Ah locus, Mol. Pharmacol. 17, 86–94 (1980).

    PubMed  CAS  Google Scholar 

  86. L. S. Birnbaum, M. M. Mcdonald, P. C. Blair, A. M. Clark, and M. W. Harris, Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah locus, Fundam. Appl. Toxicol. 15, 186–197 (1990).

    Article  PubMed  CAS  Google Scholar 

  87. N. I. Kerkvliet, L. B. Stepan, J. A. Brauner, J. A. Deyo, M. C. Henderson, R. S. Tomar, and D. R. Buhler, Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) immunotoxicity: Evidence for Ah receptor-dependent and Ah receptor-independent mechanisms of immunosuppression, Toxicol. Appl. Pharmacol. 105, 26–36 (1990).

    Article  PubMed  CAS  Google Scholar 

  88. F. H. Lin, S. J. Stohs, L. S. Birnbaum, G. Clark, G. W. Lucier, and J. A. Goldstein, The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah non-responsive C57BL/6J, Toxicol. Appl. Pharmacol. 108, 129–139 (1991).

    Article  PubMed  CAS  Google Scholar 

  89. F. H. Lin, G. Clark, L. S. Birnbaum, G. W. Lucier, and J. A. Goldstein, Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor, Mol. Pharmacol. 39, 307–313 (1991).

    PubMed  CAS  Google Scholar 

  90. B. D. Abbott and L. S. Birnbaum, TCDD alters medial epithelial cell differentiation during palatogenesis, Toxicol. Appl. Pharmacol. 99, 287–301 (1989).

    Article  PubMed  CAS  Google Scholar 

  91. B. D. Abbott, M. W. Harris, and L. S. Birnbaum, Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into the synergistic interaction occurring in embryonic palates, Teratology 45, 35–53 (1992).

    Article  PubMed  CAS  Google Scholar 

  92. G. W. Lucier, A. Tritscher, T. Goldsworthy, J. Foley, G. Clark, J. Goldstein, and R. Maronpot, Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis, Cancer Res. 51, 1391–1397 (1991).

    PubMed  CAS  Google Scholar 

  93. S. J. Stohs, B. D. Abbott, F. H. Lin, and L. S. Birnbaum, Induction of ethoxyresorufin-o-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin, Toxicology 65, 123–136(1990).

    Article  PubMed  CAS  Google Scholar 

  94. B. D. Abbott, L. S. Birnbaum, and R. M. Pratt, 2,3,7,8-TCDD-induced hyperplasia of the ureteral epithelium produces hydronephrosis in murine fetuses, Teratology 35, 329–334 (1987).

    Article  PubMed  CAS  Google Scholar 

  95. B. D. Abbott and L. S. Birnbaum, Effects of TCDD on embryonic ureteric epithelial EGF receptor expression and cell proliferation, Teratology 41, 71–84 (1990).

    Article  PubMed  CAS  Google Scholar 

  96. B. V. Madhukar, D. W. Brewster, and F. Matsumura, Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse and hamster, Proc. Natl. Acad. Sci. USA 81, 7407–7411 (1984).

    Article  PubMed  CAS  Google Scholar 

  97. T. Thunberg, Effect of TCDD on vitamin A and its relation to TCDD-toxicity, Banbury Report 18, 333–344 (1984).

    CAS  Google Scholar 

  98. C. H. Bastomsky, Enhanced thyroxine metabolism and high uptake goiter in rats after single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin, Endocrinology 101, 292–297 (1977).

    Article  PubMed  CAS  Google Scholar 

  99. M. H. Sweeney, R. W. Hornung, D. K. Wall, M. A. Fingerhut, and W. E. Halperin, Prevalence of diabetes and elevated serum glucose levels in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), presented at Dioxin ′92, Tampere, Finland, August 24-28 (1992).

    Google Scholar 

  100. W. Wolfe, J. Michalek, J. Miner, L. Needham, and D. Patterson, Jr., Diabetes versus dioxin body burdens in veterans of Operation Ranch Hand, presented at Dioxin ′92, Tampere, Finland, August 24–28 (1992).

    Google Scholar 

  101. E. Enan, P. C. C. Liu, and F. Matsumura, 2,3,7,8-TCDD causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig, J. Biol. Chem. 267, 19785–19791 (1992).

    PubMed  CAS  Google Scholar 

  102. G. W. Lucier, C. H. Sewall, J. Vanden Heuvel, J. Kanno, A. M. Tritscher, and G. C. Clark, 2,3,7,8-TCDD alterations of thyroid function in a rodent tumor promoter model, Toxicologist 13, 313 (1993).

    Google Scholar 

  103. B. A. Schweiz, J. M. Morris, G. L. Sparschu, V. K. Rowe, P. J. Gerhring, L. L. Emerson, and G. C. Gerbig, Toxicology of chlorinated dibenzo-p-dioxins, Environ. Health Perspect. 5, 87–100 (1973).

    Article  Google Scholar 

  104. J. R. Olson, M. A. Holscher, and R. A. Neal, Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the golden Syrian hamster, Toxicol. Appl. Pharmacol. 55, 67–78 (1980).

    Article  PubMed  CAS  Google Scholar 

  105. J. R. Olson and B. P. McGarrigle, Comparative developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), Chemosphere 25, 71–74 (1991).

    Article  Google Scholar 

  106. T. A. Gasiewicz, L. E. Geiger, G. Rucci, and R. A. Neal, Distribution, excretion and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J, DBA/2J and B6D2F1/J mice, Drug Metab. Dispos. 11, 397–403 (1983).

    PubMed  CAS  Google Scholar 

  107. K. M. Burbach-Dolwick, J. V. Schmidt, L. A. Carver, and C. A. Bradfield, Cloning of the human Ah-receptor cDNA, Toxicologist 13, 25 (1993).

    Google Scholar 

  108. G. W. Lucier, Humans are a sensitive species to some of the biochemical effects of structural analogs of dioxin, Environ. Toxicol. Chem. 10, 727–735 (1991).

    Article  CAS  Google Scholar 

  109. D. W. Bombick, B. V. Madhukar, D. W. Brewster, and F. Matsumura, TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes increases in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and guinea pig, Biochem. Biophys. Res. Commun. 127, 296–302 (1984).

    Article  Google Scholar 

  110. D. W. Bombick, J. Lankin, K. Tullis, and F. Matsumura, 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains, Proc. Natl. Acad. Sci. USA 85, 4128–4132 (1988).

    Article  PubMed  CAS  Google Scholar 

  111. R. W. Moore, J. A. Parsons, R. C. Bookstaff, and R. E. Peterson, Plasma concentrations of pituitary hormones in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male rats, J. Biol. Toxicol. 4, 165–172 (1989).

    Article  CAS  Google Scholar 

  112. R. C. Bookstaff, R. W. Moore, and R. E. Peterson, 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the potency of androgens and estrogens as feedback inhibitors of luteinizing hormone secretion in male rats, Toxicol. Appl. Pharmacol. 104, 212–224 (1990).

    Article  PubMed  CAS  Google Scholar 

  113. B. D. Abbott and L. S. Birnbaum, TCDD alters embryonic palatal medial epithelial cell differentiation in vitro, Toxicol. Appl. Pharmacol. 100, 119–131 (1989).

    Article  PubMed  CAS  Google Scholar 

  114. B. D. Abbott and L. S. Birnbaum, Rat embryonic palatal shelves respond to TCDD in organ culture, Toxicol. Appl. Pharmacol. 103, 441–451 (1990).

    Article  PubMed  CAS  Google Scholar 

  115. B. D. Abbott and L. S. Birnbaum, TCDD exposure of human embryonic palatal shelves in organ culture alters the differentiation of medial epithelial cells, Teratology 43, 119–132 (1991).

    Article  PubMed  CAS  Google Scholar 

  116. G. L. Eadon, J. Kaminisky, K. Silkworm, D. Aldous, P. Hilker, R. O’Keefe, J. Smith, J. Gierthy, K. Hawley, N. Kim, and A. DeCaprio, Calculation of 2,3,7,8-TCDD equivalent concentrations of complex environmental contaminant mixtures, Environ. Health Perspect. 70, 221–227 (1986).

    Article  PubMed  CAS  Google Scholar 

  117. D. Barnes, A. Alford-Stevens, L. Birnbaum, F. W. Kutz, W. Wood, and D. Patton, Toxicity equivalency factors for PCBs? Qual. Assur. Good Pract. Regul. Law. 1, 70–81 (1991).

    CAS  Google Scholar 

  118. M. J. DeVito, W. E. Maier, J. J. Diliberto, and L. S. Birnbaum, Comparative ability of various PCBs, PCDFs and TCDD to induce cytochrome P-450 1A1 and 1A2 activity following 4 weeks of treatment, Fundam. Appl. Toxicol. 20, 125–130 (1993).

    Article  CAS  Google Scholar 

  119. L. M. Sargent, G. L. Sattler, B. Roloff, Y. Xu, C. A. Sattler, L. Meisner, and H. C. Pitot, Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2′,5′-tetrachlorobiphenyl and/or 3,4,3′,4′-tetrachlorobiphenyl in rat liver, Cancer Res. 52, 955–962 (1992).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

DeVito, M.J., Birnbaum, L.S. (1994). Toxicology of Dioxins and Related Chemicals. In: Schecter, A. (eds) Dioxins and Health. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1462-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1462-0_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1464-4

  • Online ISBN: 978-1-4899-1462-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics